Schizophrenia Spectrum Disorder

Jessica Gannon, MD, is an Associate Professor of Psychiatry. This podcast describes this mental disorder, updating its definitional descriptive characteristics, noting variation, advances in treatment, e.g. long-lasting drug maintenance, reduction of unneeded components of drug RX, early intervention, team RX and the introduction of genuinely new treatments with a different mechanism of action than the traditional approach to Rx of psychosis by anti-dopamine agents.

References

Luvsannyam E, Jain MS, Pormento MKL, Siddiqui H, Balagtas ARA, Emuze BO, Poprawski T. Neurobiology of Schizophrenia: A Comprehensive Review. Cureus. 2022 Apr 8;14(4):e23959. doi: 10.7759/cureus.23959. PMID: 35541299; PMCID: PMC9080788.

Cotes RO, Ku BS, Azrin ST, Waford R, Gannon JM, Ehret M. Back to Basics: The latest on Schizophrenia Spectrum Disorders. SAMHSA Report – Released 2025. For access to full report please contact Dr. Loren Roth @ rothlh@upmc.edu